ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ANNX Annexon Inc

4.70
0.00 (0.00%)
시간외 거래
최종 업데이트: 05:02:01
15분 지연
기업명 주식 심볼 시장 주식 타입
Annexon Inc ANNX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.70 05:02:01
개장가 저가 고가 종가 전일 종가
4.76 4.645 4.90 4.69 4.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202422:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
22/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202405:15EDGAR2Form 144 - Report of proposed sale of securities
21/02/202405:12EDGAR2Form 144 - Report of proposed sale of securities
15/02/202410:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202409:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202409:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202405:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202409:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202408:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202406:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202405:45EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:41EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:39EDGAR2Form 144 - Report of proposed sale of securities
24/01/202407:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
24/01/202406:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:09EDGAR2Form 8-K - Current report
08/01/202410:00GLOBEAnnexon Outlines 2024 Priorities with Late-Stage Clinical..
30/12/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202306:50EDGAR2Form 144 - Report of proposed sale of securities
27/12/202320:30GLOBEAnnexon Biosciences to Present at the 42nd Annual J.P...
23/12/202307:28EDGAR2Form 8-K/A - Current report: [Amend]
22/12/202306:09EDGAR2Form 8-K - Current report
22/12/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/12/202307:27GLOBEAnnexon Announces Pricing of $125.0 Million Underwritten..
21/12/202307:24EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
21/12/202307:17EDGAR2Form 8-K - Current report
21/12/202307:10GLOBEAnnexon Outlines Global Registrational Program for ANX007 in..
21/12/202307:08GLOBEAnnexon Reports Phase 1 Results for ANX1502, its Oral Small..
19/12/202306:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
23/11/202306:01GLOBEAnnexon Biosciences to Participate in the 6th Annual..
14/11/202306:10EDGAR2Form 8-K - Current report
13/11/202320:30GLOBEAnnexon Reports Significant Progress with its Priority..
09/11/202320:30GLOBEAnnexon Biosciences to Participate in 2023 Jefferies London..
25/10/202305:30EDGAR2Form 8-K - Current report
24/10/202319:30GLOBEAnnexon Receives PRIME Designation from the EMA for ANX007..
19/10/202305:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
12/10/202305:44EDGAR2Form 8-K - Current report
10/10/202319:30GLOBEAnnexon Announces Clinical and Regulatory Progress for..
19/09/202319:30GLOBEAnnexon Biosciences to Participate in the 2023 Cantor Global..
19/09/202305:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..
08/08/202305:12EDGAR2Form 8-K - Current report
08/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202319:30GLOBEAnnexon Highlights Recent Pipeline and Business Progress and..
03/08/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202306:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/08/202305:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..

최근 히스토리

Delayed Upgrade Clock